NO975718L - Behandling av insulinresistens - Google Patents
Behandling av insulinresistensInfo
- Publication number
- NO975718L NO975718L NO975718A NO975718A NO975718L NO 975718 L NO975718 L NO 975718L NO 975718 A NO975718 A NO 975718A NO 975718 A NO975718 A NO 975718A NO 975718 L NO975718 L NO 975718L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- insulin resistance
- insulin
- resistance
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/62—Insulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/485,393 US6511811B1 (en) | 1995-06-07 | 1995-06-07 | Protein kinase C antagonist related to insulin receptor |
PCT/US1996/009662 WO1996040894A1 (en) | 1995-06-07 | 1996-06-07 | Treatment of insulin resistance |
Publications (2)
Publication Number | Publication Date |
---|---|
NO975718D0 NO975718D0 (no) | 1997-12-05 |
NO975718L true NO975718L (no) | 1998-02-04 |
Family
ID=23927981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975718A NO975718L (no) | 1995-06-07 | 1997-12-05 | Behandling av insulinresistens |
Country Status (7)
Country | Link |
---|---|
US (2) | US6511811B1 (no) |
EP (1) | EP0832204A4 (no) |
JP (1) | JP2001520508A (no) |
AU (1) | AU720920B2 (no) |
CA (1) | CA2223891A1 (no) |
NO (1) | NO975718L (no) |
WO (1) | WO1996040894A1 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002510653A (ja) * | 1998-04-03 | 2002-04-09 | カイロン コーポレイション | 緩衝剤としてコハク酸を含有する注射可能なigf処方物 |
WO2000062862A1 (en) * | 1999-04-15 | 2000-10-26 | South Eastern Sydney Area Health Service | Method of prophylaxis and treatment of diabetes |
US6410255B1 (en) * | 1999-05-05 | 2002-06-25 | Aurora Biosciences Corporation | Optical probes and assays |
TW200423677A (en) | 2003-04-01 | 2004-11-01 | Matsushita Electric Ind Co Ltd | Communication apparatus and authentication apparatus |
CA2445420A1 (en) * | 2003-07-29 | 2005-01-29 | Invitrogen Corporation | Kinase and phosphatase assays |
US7619059B2 (en) * | 2003-07-29 | 2009-11-17 | Life Technologies Corporation | Bimolecular optical probes |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US7803571B2 (en) * | 2003-08-16 | 2010-09-28 | Sanfoi-Aventis Deutschland GmbH | Method for identifying IRS inhibitors or agonists |
EP1508806A1 (en) * | 2003-08-16 | 2005-02-23 | Aventis Pharma Deutschland GmbH | A method for the identification of IRS protein kinase inhibitors or agonists |
ATE458200T1 (de) * | 2003-09-12 | 2010-03-15 | Life Technologies Corp | Anwendungen des resonanzenergietransfers zwischen terbium und gfp |
JP2005239629A (ja) * | 2004-02-26 | 2005-09-08 | Tendou Seiyaku Kk | インスリン受容体のリン酸化阻害剤 |
AU2006263332B2 (en) * | 2005-06-29 | 2012-02-23 | Hadasit Medical Research Services & Development Ltd. | Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
JP5151155B2 (ja) * | 2007-01-19 | 2013-02-27 | 富士通株式会社 | マイクロインジェクション用キャピラリ針の製造方法および製造装置 |
WO2011041385A2 (en) * | 2009-09-29 | 2011-04-07 | Joslin Diabetes Center, Inc. | Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis |
US8785648B1 (en) | 2010-08-10 | 2014-07-22 | The Regents Of The University Of California | PKC-epsilon inhibitors |
EP3180003B1 (en) | 2014-07-01 | 2022-01-12 | The Regents of the University of California | Pkc-epsilon inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4952567A (en) * | 1988-05-09 | 1990-08-28 | City Of Hope | Inhibition of lipogenesis |
EP0445227A4 (en) | 1988-11-23 | 1991-12-27 | The Regents Of The University Of California | Position-specific insertion vectors and method of using same |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5545636A (en) * | 1993-12-23 | 1996-08-13 | Eli Lilly And Company | Protein kinase C inhibitors |
-
1995
- 1995-06-07 US US08/485,393 patent/US6511811B1/en not_active Expired - Fee Related
-
1996
- 1996-06-07 WO PCT/US1996/009662 patent/WO1996040894A1/en not_active Application Discontinuation
- 1996-06-07 JP JP50193597A patent/JP2001520508A/ja active Pending
- 1996-06-07 EP EP96921416A patent/EP0832204A4/en not_active Withdrawn
- 1996-06-07 AU AU62647/96A patent/AU720920B2/en not_active Ceased
- 1996-06-07 CA CA002223891A patent/CA2223891A1/en not_active Abandoned
-
1997
- 1997-12-05 NO NO975718A patent/NO975718L/no unknown
-
2003
- 2003-01-28 US US10/353,812 patent/US20030211540A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2001520508A (ja) | 2001-10-30 |
EP0832204A1 (en) | 1998-04-01 |
US6511811B1 (en) | 2003-01-28 |
NO975718D0 (no) | 1997-12-05 |
US20030211540A1 (en) | 2003-11-13 |
AU720920B2 (en) | 2000-06-15 |
AU6264796A (en) | 1996-12-30 |
WO1996040894A1 (en) | 1996-12-19 |
CA2223891A1 (en) | 1996-12-19 |
EP0832204A4 (en) | 2001-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69631514D1 (de) | Steuerbarer katheter | |
NO976063D0 (no) | Fremgangsmåte for behandling av diabetes | |
DE69626168D1 (de) | Infusionskatheter | |
LV11615A (lv) | Amidi ar arstnieciskam ipasibam | |
DE69630305D1 (de) | Elektrodenkatheter | |
BR9602635A (pt) | Conjunto de cateter | |
BR9602637A (pt) | Cateter | |
DE69510024D1 (de) | Spritze | |
FI964874A (fi) | Vihannesten käsittely | |
NO982172D0 (no) | Anvendelse av epinastin for behandling av smerter | |
DK0747069T3 (da) | Implanterbar medicinsk anordning | |
DE69427970D1 (de) | Medikament gegen atopische krankheiten | |
DE69623722D1 (de) | Blutbehandlungsgerät | |
NO20001479D0 (no) | Behandling av atferdsforstyrrelse | |
FI970132A0 (fi) | Injektioruisku | |
NO975718L (no) | Behandling av insulinresistens | |
EG21712A (en) | Treatment of insulin resistance | |
NO973548D0 (no) | Behandling av diabetisk neuropati | |
FI931234A0 (fi) | Foerfarande foer oevervakning av en patients tillstaond | |
BR9507086A (pt) | Tratamento de nefroterapia diabética com valsartan | |
DE69619051D1 (de) | Behandlung von Füllstoffen mit Oxasilacycloalkanen | |
FI950389A0 (fi) | Ny medicinsk anvaendning av hemiprodukter | |
NO982562D0 (no) | Sammensetning for behandling av smerte | |
KR970000449U (ko) | 일회용 주사기 | |
NO20000274D0 (no) | Behandling av fluider |